131 related articles for article (PubMed ID: 23396256)
1. A new function of Vitamin E-TPGS in the intestinal lymphatic transport of lipophilic drugs: enhancing the secretion of chylomicrons.
Fan Z; Wu J; Fang X; Sha X
Int J Pharm; 2013 Mar; 445(1-2):141-7. PubMed ID: 23396256
[TBL] [Abstract][Full Text] [Related]
2. Enhanced oral paclitaxel absorption with vitamin E-TPGS: effect on solubility and permeability in vitro, in situ and in vivo.
Varma MV; Panchagnula R
Eur J Pharm Sci; 2005; 25(4-5):445-53. PubMed ID: 15890503
[TBL] [Abstract][Full Text] [Related]
3. Uptake of lipophilic drugs by plasma derived isolated chylomicrons: linear correlation with intestinal lymphatic bioavailability.
Gershkovich P; Hoffman A
Eur J Pharm Sci; 2005 Dec; 26(5):394-404. PubMed ID: 16140514
[TBL] [Abstract][Full Text] [Related]
4. A comparison of intestinal lymphatic transport and systemic bioavailability of saquinavir from three lipid-based formulations in the anaesthetised rat model.
Griffin BT; O'Driscoll CM
J Pharm Pharmacol; 2006 Jul; 58(7):917-25. PubMed ID: 16805951
[TBL] [Abstract][Full Text] [Related]
5. Influence of vitamin E TPGS poly(ethylene glycol) chain length on apical efflux transporters in Caco-2 cell monolayers.
Collnot EM; Baldes C; Wempe MF; Hyatt J; Navarro L; Edgar KJ; Schaefer UF; Lehr CM
J Control Release; 2006 Mar; 111(1-2):35-40. PubMed ID: 16410030
[TBL] [Abstract][Full Text] [Related]
6. Lymphatic transport of orally administered probucol-loaded mPEG-DSPE micelles.
Han L; Yang Q; Shen T; Qing J; Wang J
Drug Deliv; 2016 Jul; 23(6):1955-61. PubMed ID: 25816053
[TBL] [Abstract][Full Text] [Related]
7. Influence of vitamin E tocopherol polyethylene glycol succinate 1000 on intestinal absorption of icariside II.
Zhang Z; Lv H; Jia X; Lingling C; Xin J; Yan C; Tan X; Sun E
Pharmazie; 2012 Jan; 67(1):59-62. PubMed ID: 22393832
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of a chylomicron flow blocking approach to investigate the intestinal lymphatic transport of lipophilic drugs.
Dahan A; Hoffman A
Eur J Pharm Sci; 2005 Mar; 24(4):381-8. PubMed ID: 15734305
[TBL] [Abstract][Full Text] [Related]
9. Enhanced lymphatic transport of bioactive lipids: cell culture study of polymethoxyflavone incorporation into chylomicrons.
Yao M; Chen J; Zheng J; Song M; McClements DJ; Xiao H
Food Funct; 2013 Nov; 4(11):1662-7. PubMed ID: 24084938
[TBL] [Abstract][Full Text] [Related]
10. Inhibiting efflux with novel non-ionic surfactants: Rational design based on vitamin E TPGS.
Wempe MF; Wright C; Little JL; Lightner JW; Large SE; Caflisch GB; Buchanan CM; Rice PJ; Wacher VJ; Ruble KM; Edgar KJ
Int J Pharm; 2009 Mar; 370(1-2):93-102. PubMed ID: 19100824
[TBL] [Abstract][Full Text] [Related]
11. Intestinal lymphatic transport of halofantrine in rats assessed using a chylomicron flow blocking approach: the influence of polysorbate 60 and 80.
Lind ML; Jacobsen J; Holm R; Müllertz A
Eur J Pharm Sci; 2008 Oct; 35(3):211-8. PubMed ID: 18675904
[TBL] [Abstract][Full Text] [Related]
12. Monosodium glutamate inhibits the lymphatic transport of lipids in the rat.
Kohan AB; Yang Q; Xu M; Lee D; Tso P
Am J Physiol Gastrointest Liver Physiol; 2016 Oct; 311(4):G648-G654. PubMed ID: 27514481
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of inhibition of P-glycoprotein mediated efflux by vitamin E TPGS: influence on ATPase activity and membrane fluidity.
Collnot EM; Baldes C; Wempe MF; Kappl R; Hüttermann J; Hyatt JA; Edgar KJ; Schaefer UF; Lehr CM
Mol Pharm; 2007; 4(3):465-74. PubMed ID: 17367162
[TBL] [Abstract][Full Text] [Related]
14. Solid dispersion of berberine-phospholipid complex/TPGS 1000/SiO₂: preparation, characterization and in vivo studies.
Zhang Z; Chen Y; Deng J; Jia X; Zhou J; Lv H
Int J Pharm; 2014 Apr; 465(1-2):306-16. PubMed ID: 24456672
[TBL] [Abstract][Full Text] [Related]
15. Vitamin E-TPGS increases absorption flux of an HIV protease inhibitor by enhancing its solubility and permeability.
Yu L; Bridgers A; Polli J; Vickers A; Long S; Roy A; Winnike R; Coffin M
Pharm Res; 1999 Dec; 16(12):1812-7. PubMed ID: 10644067
[TBL] [Abstract][Full Text] [Related]
16. An in vitro examination of the impact of polyethylene glycol 400, Pluronic P85, and vitamin E d-alpha-tocopheryl polyethylene glycol 1000 succinate on P-glycoprotein efflux and enterocyte-based metabolism in excised rat intestine.
Johnson BM; Charman WN; Porter CJ
AAPS PharmSci; 2002; 4(4):E40. PubMed ID: 12646011
[TBL] [Abstract][Full Text] [Related]
17. Stimulation of triglyceride-rich lipoprotein secretion by polysorbate 80: in vitro and in vivo correlation using Caco-2 cells and a cannulated rat intestinal lymphatic model.
Seeballuck F; Lawless E; Ashford MB; O'Driscoll CM
Pharm Res; 2004 Dec; 21(12):2320-6. PubMed ID: 15648264
[TBL] [Abstract][Full Text] [Related]
18. Bioactive-Chylomicrons for Oral Lymphatic Targeting of Berberine Chloride: Novel Flow-Blockage Assay in Tissue-Based and Caco-2 Cell Line Models.
Elsheikh MA; Elnaggar YSR; Otify DY; Abdallah OY
Pharm Res; 2018 Jan; 35(1):18. PubMed ID: 29305670
[TBL] [Abstract][Full Text] [Related]
19. P-glycoprotein and surfactants: effect on intestinal talinolol absorption.
Bogman K; Zysset Y; Degen L; Hopfgartner G; Gutmann H; Alsenz J; Drewe J
Clin Pharmacol Ther; 2005 Jan; 77(1):24-32. PubMed ID: 15637528
[TBL] [Abstract][Full Text] [Related]
20. Self-assembled nanoparticles of poly(lactide)--Vitamin E TPGS copolymers for oral chemotherapy.
Zhang Z; Feng SS
Int J Pharm; 2006 Nov; 324(2):191-8. PubMed ID: 16842944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
